Effect of cyclophosphamide on the course of Candida albicans infection in normal and vaccinated mice
Japoni, A.; Mehrabani, D.; Alborzi, A.; Farshad, S.; Hayati, M.; Dehyadegari, M.A.
Saudi Medical Journal 27(1): 46-51
2006
ISSN/ISBN: 0379-5284
PMID: 16432593
Accession: 004419639
Objectives: To evaluate the immunomodulating effect of cyclophosphamide (Cy) on the course of Candida albicans (C. albicans). Methods: We performed this study in the Shiraz Medical School, Shiraz, Iran during April to November 2003. Five groups of 10 mice (vaccinated group) were immunized by 5 equal injections of 2x105, 2.5x105 and 3x105 of the organism intraperitoneally.
PDF emailed within 1 workday: $29.90
Related References
Bistoni, F.; Baccarini, M.; Blasi, E.; Marconi, P.; Puccetti, P.; Garaci, E. 1983: Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice Infection and Immunity 40(1): 46-55Escande, M.C.; Poyartsalmeron, C.; Lagrange, P.H. 1987: Effets de différents antibiotiques sur la granulopoïèse, chez la souris traitée par cyclophosphamide, dans un modèle in vivo d'infection expérimentale par C. albicans - Effects of various antibiotics on granulopoiesis in mice treated with cyclophosphamide. An in vivo model of experimental C. albicans infection Antibiotiques et Immunite. Congres 35(10bis): 1431-1434
Huppert, M.; Cazin, J.; Smith, H. 1955: Pathogenesis of Candida albicans infection following antibiotic therapy. III. The effect of antibiotics on the incidence of Candida albicans in the intestinal tract of mice Journal of Bacteriology 70(4): 440-447
Basu, S.; Quilici, C.; Zhang, H-Hua.; Grail, D.; Dunn, A.R. 2008: Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans Growth Factors 26(1): 23-34
Ito, S.; Pedras-Vasconcelos, J.; Klinman, D.M. 2005: CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans Infection and Immunity 73(9): 6154-6156
Steinshamn, S.; Waage, A. 1992: Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice Infection and Immunity 60(10): 4003-4008
Khardori, N.; Nguyen, H.; Stephens, L.C.; Kalvakuntla, L.; Rosenbaum, B.; Bodey, G.P. 1993: Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice Antimicrobial Agents and ChemoTherapy 37(4): 729-736
Van t Wout, J.W.; Mattie, H.; van Furth, R. 1989: Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice Antimicrobial Agents and ChemoTherapy 33(2): 147-151
Lagrange, P.H.; Fourgeaud, M.; Neway, T.; Pilet, C. 1994: Enhanced resistance against lethal disseminated Candida albicans infection in mice treated with polar glycopeptidolipids from Mycobacterium chelonae (pGPL-Mc) - Augmentation de la résistance des souris traitées par des glycopeptidolipides polaires de Mycobacterium chelonae (GPLp-Mc) vis-à-vis de l'infection létale induite par Candida albicans Comptes Rendus de l'Academie des Sciences. Serie 3, Sciences de la Vie 317(12): 1107-1113
Reyes, A.C.; Reyes, A. 1956: Studies on Candida albicans infection in Filipino children. I. Occurrence of C. albicans in the normal mouth Acta Medica Philippina 13(1-4): 147-150
Samonis, G.; Karyotakis, N.C.; Anaissie, E.J.; Barbounakis, E.; Maraki, S.; Tselentis, Y.; Bodey, G.P. 1996: Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans Antimicrobial Agents and ChemoTherapy 40(9): 2221-2223
Dimitrova, P.; Yordanov, M.; Danova, S.; Ivanovska, N. 2008: Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA Fems Immunology and Medical Microbiology 53(2): 231-236
Van Wyk, C.W.; van der Bijl, P.; Cooper, R.C. 1995: Induced resistance to Candida albicans in BALB/c mice during short-term immunosuppression with cyclophosphamide Laboratory Animal Science 45(1): 101-106
Eng, R.H.K.; Person, A.; Chmel, H. 1981: The fate of candida albicans antigens in experimental candida infection in mice Clinical Research 29(2): 384A
Tansho, S.; Ab, S.; Mizutani, S.; Ono, Y.; Takesako, K.; Yamaguchi, H. 2002: Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen Microbiology and Immunology 46(5): 307-311
Shalit, I.; Horev-Azaria, L.; Fabian, I.; Blau, H.; Kariv, N.; Shechtman, I.; Alteraz, H.; Kletter, Y. 2002: Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide Antimicrobial Agents and ChemoTherapy 46(8): 2442-2449
Shroff, A.; Sequeira, R.; Patel, V.; Reddy, K.V.R. 2018: Data on autophagy markers and anti-candida cytokines expression in mice in response to vaginal infection of Candida albicans Data in Brief 18: 432-440
Boumahni, B.; Piyaraly, S.; Masson, D.; Djemili, S.; Edmar, A.; Randrianaly, E.; Mariette, J.B. 1998: Infection materno-fœtale systémique à Candida albicans - Systemic maternofetal Candida albicans infection Annales de Pediatrie (Paris) 45(2): 89-92
Qi, Y.; Hu, X.; Cui, J.; Chen, J.; Wu, Q.; Sun, X.; Shi, Y. 2018: Combined use of insoluble β-glucan from the cell wall of Candida albicans and cyclophosphamide: Validation in S180 tumor-bearing mice Biomedicine and PharmacoTherapy 97: 1366-1372
Angulo, Iñigo.; Jiménez-Díaz, Mía.Belén.; García-Bustos, Jé.Francisco.; Gargallo, D.; de las Heras, F.Gómez.; Muñoz-Fernández, Mía.Angeles.; Fresno, M. 2002: Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production Cellular Immunology 218(1-2): 46-58